Hemoadsorption with CytoSorb as part of an individualized therapy in critically-ill patients
Chair: Manu Malbrain, Leuven, Belgium and Yatin Mehta, Gurgaon, India

How to balance sepsis campaign guidelines and the need for patient tailored care?
Axel Nierhaus, Hamburg, Germany

Use of CytoSorb in different pediatric indications – an overview
Gabriella Bottari, Rome, Italy

Hemoadsorption in severe rhabdomyolysis and for prevention of DOAC associated bleeding complications
Dietmar Fries, Innsbruck, Austria